QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT07049185 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07049185
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2027-03-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.